A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors
Author:
Funder
Science and Technology Program of Guangzhou
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00277-024-05691-2.pdf
Reference28 articles.
1. Shetty MG, Pai P, Deaver RE et al (2021) Histone deacetylase 2 selective inhibitors: a versatile therapeutic strategy as next generation drug target in cancer therapy. Pharmacol Res 170:105695
2. Shvedunova M, Akhtar A (2022) Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol 23:329–349
3. Shah R (2019) Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology. Drug Saf 42:235–245
4. Bondarev A, Attwood M, Jonsson J et al (2021) Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol 87:4577–4597
5. Schaefer E, Loaiza-Bonilla A, Juckett M et al (2009) A phase 2 study of vorinostat in acute myeloid leukemia. Haematologica 94:1375–1382
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications;Cell Chemical Biology;2024-08
2. The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity;Basic Research in Cardiology;2024-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3